Centocor Inc. and Tocor II Inc. have filed to increase theproposed public offering of Tocor II units from 1.5 million unitsto 2 million units, Centocor said on Wednesday.
Each unit consists of one callable common share of Tocor II, onewarrant to purchase a common share of Centocor(NASDAQ:CNTO) and one callable warrant to purchase acommon share of Centocor.
Tocor II, a research and development funding vehicle, willcontract with Centocor to conduct R&D of small peptidemolecule drugs. Shares of Malvern, Pa.-based Centocor closeddown $3.50 at $56.25.
(c) 1997 American Health Consultants. All rights reserved.